Molecular mechanisms of endothelial dysfunction in Kawasaki-disease-associated vasculitis

Yu Qiu1, Yulin Zhang1, Yifei Li1

  • 1Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education (MOE), Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.

Insights

Kawasaki disease (KD) damages coronary arteries in young children. This review details how endothelial cell injury drives KD pathogenesis and discusses potential therapeutic strategies targeting these critical cells.

Area of Science:

  • Pediatric vasculitis
  • Cardiovascular pathology
  • Immunoinflammation

Background:

  • Kawasaki disease (KD) is a leading cause of acquired heart disease in children.
  • It involves acute inflammation of blood vessels, particularly coronary arteries.
  • Endothelial cells lining the coronary arteries are primary targets, leading to potential cardiac complications.

Purpose of the Study:

  • To systematically review the role of endothelial cells in Kawasaki disease pathogenesis.
  • To explore current and potential therapeutic strategies targeting endothelial dysfunction in KD.

Main Methods:

  • Literature review of studies on Kawasaki disease and endothelial cell biology.
  • Analysis of mechanisms underlying endothelial cell damage in KD.
  • Evaluation of therapeutic approaches for endothelial protection.

Main Results:

  • Endothelial cells are central to KD pathogenesis, exhibiting damage and dysfunction.
  • Inflammatory processes directly impact the endothelium, initiating vascular injury.
  • Current treatments face challenges, highlighting the need for targeted endothelial therapies.

Conclusions:

  • Understanding endothelial cell involvement is crucial for managing Kawasaki disease.
  • Targeting endothelial dysfunction offers promising therapeutic avenues for KD patients.
  • Further research into endothelial protection is vital for preventing long-term cardiovascular sequelae.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
28
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
45
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.8K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
624